featured
Regorafenib Plus Nivolumab for Unresectable Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Nat. Med. 2024 Feb 19;[EPub Ahead of Print], HD Kim, S Jung, HY Lim, BY Ryoo, MH Ryu, S Chuah, HJ Chon, B Kang, JY Hong, HC Lee, DB Moon, KH Kim, TW Kim, D Tai, V Chew, JS Lee, RS Finn, JY Koh, C YooFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.